PC001- A Study to Evaluate the Usability of PointCheck

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

NeoplasmsNeutropenia

Interventions

DIAGNOSTIC_TEST

PointCheck

This is a usability study on PointCheck, a new technology to detect chemotherapy-induced neutropenia

Trial Locations (1)

RECRUITING

Boston Medical Center, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Leuko Labs, Inc.

INDUSTRY

NCT04448301 - PC001- A Study to Evaluate the Usability of PointCheck | Biotech Hunter | Biotech Hunter